PRISM MediaWire

Medical Devices

Nexalin Tackles Sleepless Nights with Innovative Insomnia Device

New York, March 07, 2024 - PRISM MediaWire - In a world where stress and anxiety have become prevalent, sleep disorders like insomnia have emerged as significant health concerns affecting millions of individuals globally. Sleeplessness not only impacts one's physical wel...

7 March 2024

Medical Devices

Neuronetics Announces Substantial Growth in 2023, Enhances Accessibility to Neurohealth Therapy; Stock Prices Surge by 23%

New York, March 06, 2024 - PRISM MediaWire - Neuronetics, Inc. (NASDAQ: STIM), a prominent medical technology firm focused on neurohealth therapies, disclosed notable financial and operational milestones for the fourth quarter and full-year of 2023. The company has achie...

6 March 2024

Electric Vehicles

GreenPower Introduces Newest Innovation: GP Truck Body, Enhancing One-Stop EV Solution

New York, March 06, 2024 - PRISM MediaWire - GreenPower Motor Company Inc. (NASDAQ: GP) (TSXV: GPV), renowned for its lineup of all-electric, zero-emission medium and heavy-duty vehicles, has initiated the establishment of GP Truck Body, a novel business segment dedicate...

6 March 2024

Lipella Pharmaceuticals to Progress Development of Oral Graft-versus-Host-Disease Treatment Candidate

New York, March 06, 2024 - PRISM MediaWire - "Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) secures FDA Approval for Investigational New Drug (IND) Application, Advancing Clinical Testing of LP-410 for Oral Graft-Versus-Host Disease (GvHD) Treatment. Clinical Study Set to ...

6 March 2024

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

New York, March 06, 2024 - PRISM MediaWire - SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX's introduction ...

6 March 2024

IceCure's ProSense® Achieves Complete Tumor Reduction in Early-Stage Breast Cancer

New York, March 06, 2024 - PRISM MediaWire - IceCure Medical Ltd. (Nasdaq: ICCM) has disclosed novel findings from an initial, autonomous breast cancer investigation, revealing a median tumor reduction of 100% at both six and twelve months subsequent to cryoablation in w...

6 March 2024

Sports Gear and Apparel

DRYWORLD Brands (IBGR) Strategically Positions Itself for Game-Changing Impact in 2024 Following Dynamic Moves in 2023

New York, March 05, 2024 - PRISM MediaWire - Today, DRYWORLD Brands, Inc. ($IBGR), a leading global sports brand renowned for premium performance, delivered its annual corporate update to the investment community. The update showcased remarkable achievements, including a...

5 March 2024

Topline Data Anticipated for Suicidal Bipolar Depression Treatment Trial by NRx

New York, March 05, 2024 - PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) achieves 'Last Patient, Last Visit' milestone in Phase 2b/3 Trial of NRX-101 for suicidal treatment-resistant bipolar depression. The company confirms completion of the 74th and final e...

5 March 2024

Quoin Pharmaceuticals Expands Rare Disease Clinical Trials to Encompass Teen Patients

New York, March 04, 2024 - PRISM MediaWire - Clinical-stage biotechnology firm Quoin Pharmaceuticals (Nasdaq: QNRX) has obtained FDA clearance to enroll subjects aged 14 years and above into its two ongoing clinical trials for QRX003. These trials are dedicated to assess...

4 March 2024

Artificial Intelligence:

Advancements in Artificial Intelligence Enhance Travel Experience in 2024: TSA Precheck and Airlines Introduce "Touchless ID" System; BBAI Stock Surges Approximately 30% Following Announcement of "Vision AI" Acquisition

New York, March 04, 2024 - PRISM MediaWire - United Airlines (UA) is set to introduce "Touchless ID" technology, replacing traditional boarding passes and IDs for passengers traveling through Chicago O'Hare and Los Angeles International airports. The program is slated fo...

4 March 2024